167 related articles for article (PubMed ID: 23391418)
1. Distinct CD44 splice variants differentially affect collateral artery growth.
Bot PT; Grundmann S; van Royen N; Joosten SP; Schirmer SH; de Kleijn DP; Pals ST; Pasterkamp G; Piek JJ; Hoefer IE
Curr Vasc Pharmacol; 2013 Jan; 11(1):13-20. PubMed ID: 23391418
[TBL] [Abstract][Full Text] [Related]
2. CD44 regulates arteriogenesis in mice and is differentially expressed in patients with poor and good collateralization.
van Royen N; Voskuil M; Hoefer I; Jost M; de Graaf S; Hedwig F; Andert JP; Wormhoudt TA; Hua J; Hartmann S; Bode C; Buschmann I; Schaper W; van der Neut R; Piek JJ; Pals ST
Circulation; 2004 Apr; 109(13):1647-52. PubMed ID: 15023889
[TBL] [Abstract][Full Text] [Related]
3. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon.
Jackson DG; Bell JI; Dickinson R; Timans J; Shields J; Whittle N
J Cell Biol; 1995 Feb; 128(4):673-85. PubMed ID: 7532175
[TBL] [Abstract][Full Text] [Related]
4. Heparan sulfate enhances invasion by human colon carcinoma cell lines through expression of CD44 variant exon 3.
Kuniyasu H; Oue N; Tsutsumi M; Tahara E; Yasui W
Clin Cancer Res; 2001 Dec; 7(12):4067-72. PubMed ID: 11751503
[TBL] [Abstract][Full Text] [Related]
5. CD44v3-v10 reduces the profibrotic effects of TGF-β1 and attenuates tubular injury in the early stage of chronic obstructive nephropathy.
Rampanelli E; Rouschop K; Teske GJ; Claessen N; Leemans JC; Florquin S
Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1445-54. PubMed ID: 24026183
[TBL] [Abstract][Full Text] [Related]
6. Opposite role of CD44-standard and CD44-variant-3 in tubular injury and development of renal fibrosis during chronic obstructive nephropathy.
Rampanelli E; Rouschop KM; Claessen N; Teske GJ; Pals ST; Leemans JC; Florquin S
Kidney Int; 2014 Sep; 86(3):558-69. PubMed ID: 24717295
[TBL] [Abstract][Full Text] [Related]
7. CD44 splicing pattern is associated with disease progression in pulmonary adenocarcinoma.
Lee LN; Kuo SH; Lee YC; Chang YL; Chang HC; Jan IS; Yang PC
J Formos Med Assoc; 2005 Aug; 104(8):541-8. PubMed ID: 16193174
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of CD44v3 variant isoform is associated with unfavorable outcome in non-small cell lung carcinoma.
Pirinen R; Hirvikoski P; Böhm J; Kellokoski J; Moisio K; Virén M; Johansson R; Hollmén S; Kosma VM
Hum Pathol; 2000 Sep; 31(9):1088-95. PubMed ID: 11014576
[TBL] [Abstract][Full Text] [Related]
9. Splicing factor Tra2-beta1 is specifically induced in breast cancer and regulates alternative splicing of the CD44 gene.
Watermann DO; Tang Y; Zur Hausen A; Jäger M; Stamm S; Stickeler E
Cancer Res; 2006 May; 66(9):4774-80. PubMed ID: 16651431
[TBL] [Abstract][Full Text] [Related]
10. hnRNP L inhibits CD44 V10 exon splicing through interacting with its upstream intron.
Loh TJ; Cho S; Moon H; Jang HN; Williams DR; Jung DW; Kim IC; Ghigna C; Biamonti G; Zheng X; Shen H
Biochim Biophys Acta; 2015 Jun; 1849(6):743-50. PubMed ID: 25623890
[TBL] [Abstract][Full Text] [Related]
11. Influence of epitopes CD44v3 and CD44v6 in the invasive behavior of fibroblast-like synoviocytes derived from rheumatoid arthritic joints.
Wibulswas A; Croft D; Pitsillides AA; Bacarese-Hamilton I; McIntyre P; Genot E; Kramer IM
Arthritis Rheum; 2002 Aug; 46(8):2059-64. PubMed ID: 12209509
[TBL] [Abstract][Full Text] [Related]
12. Impaired arteriogenesis in syndecan-1(-/-) mice.
Tang GL; Weitz K
J Surg Res; 2015 Jan; 193(1):22-7. PubMed ID: 25194470
[TBL] [Abstract][Full Text] [Related]
13. CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor.
Bennett KL; Jackson DG; Simon JC; Tanczos E; Peach R; Modrell B; Stamenkovic I; Plowman G; Aruffo A
J Cell Biol; 1995 Feb; 128(4):687-98. PubMed ID: 7532176
[TBL] [Abstract][Full Text] [Related]
14. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility of CD44 standard, CD44v6, and CD44v3-10 expression in adenocarcinomas presenting in serous fluids.
Afify A; Pang L; Howell L
Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):446-50. PubMed ID: 18091389
[TBL] [Abstract][Full Text] [Related]
16. Conservation of CD44 exon v3 functional elements in mammals.
Vela E; Hilari JM; Delclaux M; Fernández-Bellon H; Isamat M
BMC Res Notes; 2008 Jul; 1():57. PubMed ID: 18710510
[TBL] [Abstract][Full Text] [Related]
17. Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2.
Heil M; Ziegelhoeffer T; Wagner S; Fernández B; Helisch A; Martin S; Tribulova S; Kuziel WA; Bachmann G; Schaper W
Circ Res; 2004 Mar; 94(5):671-7. PubMed ID: 14963007
[TBL] [Abstract][Full Text] [Related]
18. Heparan sulfate composition of alternatively spliced CD44 fusion proteins.
Piepkorn M; Hovingh P; Bennett KL; Linker A
Biochem Biophys Res Commun; 1999 Apr; 257(3):839-42. PubMed ID: 10208870
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel splice variants of the human CD44 gene.
Vela E; Roca X; Isamat M
Biochem Biophys Res Commun; 2006 Apr; 343(1):167-70. PubMed ID: 16530165
[TBL] [Abstract][Full Text] [Related]
20. Interferon-beta signaling is enhanced in patients with insufficient coronary collateral artery development and inhibits arteriogenesis in mice.
Schirmer SH; Fledderus JO; Bot PT; Moerland PD; Hoefer IE; Baan J; Henriques JP; van der Schaaf RJ; Vis MM; Horrevoets AJ; Piek JJ; van Royen N
Circ Res; 2008 May; 102(10):1286-94. PubMed ID: 18420941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
